Treatment OutcomeProspective StudiesClinical Trials as TopicClinical Trials, Phase III as TopicDouble-Blind MethodResearch DesignClinical Trials, Phase II as TopicClinical Trials, Phase I as TopicControlled Clinical Trials as TopicPlacebosTime FactorsClinical ProtocolsFollow-Up StudiesPatient SelectionEarly Termination of Clinical TrialsSingle-Blind MethodMulticenter Studies as TopicClinical Trials Data Monitoring CommitteesDrug Administration ScheduleDrug Therapy, CombinationSample SizeQuality of LifeCost-Benefit AnalysisAntineoplastic Combined Chemotherapy ProtocolsPilot ProjectsClinical Trials, Phase IV as TopicOutcome Assessment (Health Care)NeoplasmsAntineoplastic AgentsCombined Modality TherapySurvival AnalysisPatient ComplianceAdministration, OralSeverity of Illness IndexRecurrenceCross-Over StudiesIntention to Treat AnalysisEvidence-Based MedicineRisk FactorsDose-Response Relationship, DrugDietary SupplementsQuestionnairesDisease-Free SurvivalFeasibility StudiesExercise TherapyRandom Allocation